"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"p53 signaling pathway"	66	-0.18395	0.48884	1	0.18395	0.51116	0.83994	-0.75589	0.19123	0.33439	34	-1.1199	0.29756	0.47745	32	0.068826	0.36066	0.62314
"2"	"mTOR signaling pathway"	147	0.89504	0.10502	0.72174	-0.89504	0.89498	1	2.2294	4.2878e-05	0.0013422	80	1.3679	6.6737e-05	0.0028199	67	1.8075	0.021614	0.16004
"3"	"mRNA surveillance pathway"	88	2.8933	0.0005789	0.045277	-2.8933	0.99942	1	-2.0029	0.44897	0.59295	55	0.24184	0.010712	0.058445	32	-2.1872	0.94462	1
"4"	"cGMP-PKG signaling pathway"	162	0.26484	0.24682	1	-0.26484	0.75318	0.97023	2.0642	7.8149e-05	0.0017472	84	1.549	5.4292e-05	0.0028199	78	1.3673	0.042284	0.20533
"5"	"cAMP signaling pathway"	185	-0.32151	0.45814	1	0.32151	0.54186	0.86173	1.3297	0.00020294	0.0030247	98	-0.010805	0.0037267	0.027378	87	1.9505	0.013169	0.11456
"6"	"beta-Alanine metabolism"	31	1.4317	0.051116	0.47057	-1.4317	0.94888	1	0.088849	0.13641	0.25566	19	0.55012	0.052019	0.17029	12	-0.54941	0.63462	0.84707
"7"	"alpha-Linolenic acid metabolism"	22	-0.54918	0.66634	1	0.54918	0.33366	0.65684	-1.4135	0.61902	0.73952	13	-2.1825	0.85029	0.9616	9	0.41298	0.30693	0.58786
"8"	"Wnt signaling pathway"	139	-0.3473	0.51521	1	0.3473	0.48479	0.81739	0.9052	0.0015217	0.0099229	72	-0.0095726	0.0099655	0.055344	67	1.3137	0.057231	0.2342
"9"	"Vitamin digestion and absorption"	23	-0.12205	0.51426	1	0.12205	0.48574	0.81739	-2.4504	0.86207	0.92297	15	-3.0906	0.96368	1	8	0.076983	0.4215	0.68889
"10"	"Vitamin B6 metabolism"	8	0.61493	0.23776	1	-0.61493	0.76224	0.97023	0.050672	0.28146	0.43184	6	-0.63886	0.47155	0.65179	2	1.2079	0.11519	0.33482
"11"	"Viral myocarditis"	71	-1.6004	0.92291	1	1.6004	0.077094	0.32804	-0.53292	0.14479	0.26816	28	-0.65983	0.1971	0.37839	43	-0.15234	0.42388	0.68889
"12"	"Viral carcinogenesis"	209	0.2482	0.23435	1	-0.2482	0.76565	0.97023	-3.8693	0.68487	0.8035	101	-1.8007	0.13689	0.3085	108	-3.6413	0.99666	1
"13"	"Vasopressin-regulated water reabsorption"	42	-0.12957	0.47409	1	0.12957	0.52591	0.8508	-1.1843	0.41927	0.56546	21	-1.1089	0.3974	0.58024	21	-0.56589	0.62108	0.83981
"14"	"Vascular smooth muscle contraction"	122	0.7605	0.13155	0.79182	-0.7605	0.86845	1	0.60888	0.0071828	0.030381	68	-0.010729	0.010938	0.058652	54	0.92724	0.11757	0.33547
"15"	"Valine, leucine and isoleucine degradation"	53	2.8405	0.00093896	0.045277	-2.8405	0.99906	1	-2.5951	0.76798	0.86778	37	-1.0284	0.25458	0.44232	16	-3.1593	0.99541	1
"16"	"Valine, leucine and isoleucine biosynthesis"	3	0.69764	0.2353	1	-0.69764	0.7647	0.97023	-0.18445	0.42636	0.5703	2	0.21682	0.27736	0.46151	1	-0.6261	0.71992	0.89918
"17"	"VEGF signaling pathway"	55	-2.3169	0.98412	1	2.3169	0.015885	0.13811	1.9927	0.002209	0.012571	23	-0.034493	0.10666	0.26326	32	2.6417	0.0049067	0.069363
"18"	"Ubiquitin mediated proteolysis"	136	2.7186	0.00099627	0.045277	-2.7186	0.999	1	-1.1945	0.12017	0.23218	78	0.79422	0.00084273	0.0095669	58	-2.7502	0.98292	1
"19"	"Ubiquinone and other terpenoid-quinone biosynthesis"	10	-0.20214	0.54299	1	0.20214	0.45701	0.78596	0.17716	0.24085	0.38859	5	-0.15644	0.30959	0.48097	5	0.40699	0.31071	0.58786
"20"	"Tyrosine metabolism"	37	-1.2628	0.87465	1	1.2628	0.12535	0.42189	-0.86968	0.34354	0.50013	22	-2.6062	0.87319	0.96342	15	1.7904	0.038577	0.19996
"21"	"Type II diabetes mellitus"	45	-0.59551	0.67176	1	0.59551	0.32824	0.6562	-0.633	0.23669	0.38569	22	-1.0602	0.38975	0.57406	23	0.15151	0.37044	0.6365
"22"	"Type I diabetes mellitus"	53	-1.7292	0.93837	1	1.7292	0.061626	0.31565	-2.8539	0.82595	0.90534	18	-1.3983	0.57291	0.75819	35	-2.5092	0.97606	1
"23"	"Tuberculosis"	159	-3.0378	0.99592	1	3.0378	0.0040801	0.065544	1.4187	0.00024321	0.0031552	67	-0.47054	0.034518	0.13942	92	2.2667	0.0075915	0.086604
"24"	"Tryptophan metabolism"	44	0.75341	0.15957	0.83985	-0.75341	0.84043	1	-2.488	0.78707	0.87156	27	-1.9866	0.67535	0.83017	17	-1.4991	0.89009	0.99575
"25"	"Transcriptional misregulation in cancer"	165	-0.26651	0.44502	1	0.26651	0.55498	0.86422	0.11106	0.0075887	0.03167	82	-0.3702	0.016194	0.078692	83	0.52455	0.18496	0.44247
"26"	"Toxoplasmosis"	106	-3.1463	0.99861	1	3.1463	0.0013907	0.031114	0.82723	0.0063622	0.027279	42	-1.3035	0.29743	0.47745	64	2.1206	0.010523	0.10909
"27"	"Toll-like receptor signaling pathway"	86	-0.93309	0.74503	1	0.93309	0.25497	0.59557	-0.28511	0.064413	0.14401	41	-0.80569	0.16333	0.34584	45	0.3749	0.2463	0.52108
"28"	"Tight junction"	160	-0.88778	0.68426	1	0.88778	0.31574	0.64776	-0.064766	0.010347	0.038553	80	-1.1689	0.071599	0.20243	80	1.0773	0.084639	0.28297
"29"	"Thyroid hormone synthesis"	72	1.761	0.023437	0.30566	-1.761	0.97656	1	-1.4839	0.38009	0.53831	45	-1.1072	0.20212	0.38564	27	-0.99374	0.75788	0.9159
"30"	"Thyroid hormone signaling pathway"	114	1.0922	0.076004	0.58074	-1.0922	0.924	1	2.3542	0.00010061	0.0018888	63	1.548	0.00010189	0.0028199	51	1.7992	0.023855	0.16191
"31"	"Thyroid cancer"	28	-0.72914	0.72662	1	0.72914	0.27338	0.61254	1.0713	0.038265	0.094308	12	0.7346	0.052715	0.17076	16	0.78098	0.21247	0.47757
"32"	"Thiamine metabolism"	13	-0.97709	0.81182	1	0.97709	0.18818	0.51667	-0.36995	0.34786	0.50175	6	-1.1219	0.64466	0.8072	7	0.53448	0.26445	0.54466
"33"	"Th17 cell differentiation"	97	-1.4644	0.88722	1	1.4644	0.11278	0.39663	0.99933	0.0045456	0.02062	44	-0.1759	0.051218	0.17	53	1.5122	0.045384	0.2054
"34"	"Th1 and Th2 cell differentiation"	84	-2.3417	0.98603	1	2.3417	0.01397	0.1286	-0.48025	0.11974	0.23218	36	-1.8043	0.51646	0.69276	48	0.92727	0.12924	0.35569
"35"	"Terpenoid backbone biosynthesis"	21	2.2289	0.0073188	0.22714	-2.2289	0.99268	1	0.72013	0.075429	0.15808	16	0.64067	0.047329	0.16589	5	0.32976	0.33625	0.6081
"36"	"Taurine and hypotaurine metabolism"	10	2.0301	0.014721	0.27228	-2.0301	0.98528	1	-0.0098872	0.29007	0.43951	7	1.1014	0.048006	0.16589	3	-1.7005	0.92253	1
"37"	"Taste transduction"	54	-1.0133	0.78728	1	1.0133	0.21272	0.54695	-3.32	0.90318	0.95829	27	-3.6829	0.97938	1	27	-1.0123	0.76327	0.91651
"38"	"TNF signaling pathway"	105	0.20626	0.31605	1	-0.20626	0.68395	0.94306	0.54834	0.0097043	0.037655	54	0.73352	0.0032945	0.02499	51	0.03201	0.34003	0.61127
"39"	"TGF-beta signaling pathway"	80	0.1555	0.32313	1	-0.1555	0.67687	0.93983	-0.30512	0.073648	0.15789	39	0.34925	0.02045	0.097847	41	-0.76683	0.65503	0.85594
"40"	"T cell receptor signaling pathway"	100	-0.51475	0.58769	1	0.51475	0.41231	0.73473	0.45535	0.013897	0.04871	54	-0.74961	0.091528	0.23525	46	1.4836	0.050394	0.21415
"41"	"Systemic lupus erythematosus"	120	-2.5728	0.99237	1	2.5728	0.0076297	0.099504	-9.1009	1	1	52	-5.6968	0.99952	1	62	-1.1885	0.75318	0.91563
"42"	"Synthesis and degradation of ketone bodies"	9	-0.6247	0.71374	1	0.6247	0.28626	0.62658	-1.8562	0.81731	0.90077	3	-1.0821	0.68598	0.83992	6	-1.5082	0.88966	0.99575
"43"	"Synaptic vesicle cycle"	59	0.18405	0.32761	1	-0.18405	0.67239	0.93983	-0.80397	0.21563	0.3625	31	-0.81721	0.23099	0.42356	28	-0.30717	0.50761	0.75119
"44"	"Sulfur relay system"	7	-0.039059	0.48768	1	0.039059	0.51232	0.83994	-2.2877	0.89669	0.95464	4	-1.8493	0.87109	0.96342	3	-1.3592	0.87038	0.99518
"45"	"Sulfur metabolism"	10	0.32373	0.33343	1	-0.32373	0.66657	0.93983	-0.41612	0.4104	0.56214	7	-0.96009	0.5609	0.74547	3	0.70682	0.25712	0.53667
"46"	"Steroid hormone biosynthesis"	85	-0.22982	0.45149	1	0.22982	0.54851	0.86222	-7.4654	1	1	37	-3.9436	0.97647	1	47	-5.343	1	1
"47"	"Steroid biosynthesis"	18	-1.9853	0.97037	1	1.9853	0.029628	0.20608	-0.33652	0.3148	0.4626	5	-1.4216	0.74934	0.88275	13	0.48565	0.28557	0.58
"48"	"Starch and sucrose metabolism"	32	-0.50988	0.63017	1	0.50988	0.36983	0.69884	-0.99183	0.38791	0.53962	15	-0.7265	0.36049	0.539	17	-0.67835	0.69103	0.87351
"49"	"Staphylococcus aureus infection"	47	-4.5095	1	1	4.5095	2.3608e-06	0.00036946	1.9214	0.0032389	0.01536	15	-1.7539	0.71843	0.86601	32	3.5294	0.00040383	0.031398
"50"	"Spliceosome"	127	2.6996	0.0011572	0.045277	-2.6996	0.99884	1	-2.5764	0.49748	0.63816	74	0.058042	0.0062664	0.039772	52	-2.9571	0.98933	1
"51"	"Sphingolipid signaling pathway"	117	-0.25223	0.46995	1	0.25223	0.53005	0.8508	1.4607	0.00080966	0.0065101	58	1.1198	0.00099001	0.010021	59	0.94673	0.11673	0.33547
"52"	"Sphingolipid metabolism"	44	-1.276	0.86291	1	1.276	0.13709	0.43555	-0.31774	0.18182	0.32153	17	-0.11343	0.16429	0.34584	27	-0.31561	0.52659	0.76749
"53"	"Small cell lung cancer"	81	-1.4515	0.89957	1	1.4515	0.10043	0.37421	1.4888	0.0019542	0.01178	35	0.74663	0.0095118	0.053785	46	1.3243	0.066403	0.25814
"54"	"Signaling pathways regulating pluripotency of stem cells"	133	-0.82747	0.69555	1	0.82747	0.30445	0.63529	1.3619	0.00088725	0.0066121	69	-0.55686	0.040923	0.15172	64	2.5414	0.003548	0.06445
"55"	"Serotonergic synapse"	122	-0.75295	0.66876	1	0.75295	0.33124	0.6562	-2.708	0.55585	0.68228	57	-2.2928	0.50315	0.68934	65	-1.5629	0.82164	0.95704
"56"	"Selenocompound metabolism"	16	0.2584	0.35416	1	-0.2584	0.64584	0.93156	-0.88685	0.48799	0.62878	7	0.22746	0.18569	0.36783	9	-1.3831	0.85643	0.98284
"57"	"Salmonella infection"	76	-1.2159	0.8507	1	1.2159	0.1493	0.43984	0.7722	0.014566	0.049558	30	1.0642	0.0073113	0.045476	46	0.13316	0.31871	0.58786
"58"	"Salivary secretion"	74	-1.5418	0.90982	1	1.5418	0.090183	0.36189	1.4831	0.0028051	0.013937	33	0.25897	0.036623	0.14237	41	1.7602	0.032431	0.1903
"59"	"SNARE interactions in vesicular transport"	31	0.50779	0.24808	1	-0.50779	0.75192	0.97023	-0.92434	0.38607	0.53947	15	0.038641	0.146	0.32666	16	-1.324	0.84623	0.97473
"60"	"Ribosome biogenesis in eukaryotes"	77	1.7078	0.021986	0.30566	-1.7078	0.97801	1	-2.5564	0.66979	0.79111	50	-2.0445	0.49416	0.68002	27	-1.535	0.88581	0.99575
"61"	"Ribosome"	128	-0.77165	0.67464	1	0.77165	0.32536	0.6562	-3.1649	0.68541	0.8035	62	-2.9691	0.73409	0.87472	66	-1.5298	0.84018	0.97473
"62"	"Riboflavin metabolism"	7	-0.22036	0.55915	1	0.22036	0.44085	0.77088	1.1737	0.078315	0.16042	4	0.26378	0.21162	0.4013	3	1.4882	0.092479	0.30275
"63"	"Rheumatoid arthritis"	77	-2.8791	0.99581	1	2.8791	0.0041881	0.065544	0.58128	0.022054	0.065122	25	0.1796	0.065243	0.19243	52	0.58282	0.21071	0.47757
"64"	"Retrograde endocannabinoid signaling"	133	-1.1483	0.80504	1	1.1483	0.19496	0.53062	-1.8971	0.29066	0.43951	67	-2.8381	0.63752	0.8027	66	0.16644	0.30992	0.58786
"65"	"Retinol metabolism"	86	-0.72798	0.67083	1	0.72798	0.32917	0.6562	-6.6462	0.99983	1	40	-4.5172	0.99384	1	45	-3.7053	0.99897	1
"66"	"Renin-angiotensin system"	27	0.42189	0.2821	1	-0.42189	0.7179	0.96353	-3.711	0.98076	1	14	-2.0359	0.79599	0.92508	13	-3.2354	0.99727	1
"67"	"Renin secretion"	65	-1.179	0.85882	1	1.179	0.14118	0.43752	0.70234	0.020214	0.062028	29	0.51444	0.027105	0.11873	35	1.8765	0.026088	0.17262
"68"	"Renal cell carcinoma"	63	1.3313	0.057107	0.49168	-1.3313	0.94289	1	0.82691	0.016635	0.053131	37	0.90258	0.0079195	0.047364	26	0.21047	0.3314	0.60628
"69"	"Regulation of lipolysis in adipocytes"	52	-0.90547	0.75773	1	0.90547	0.24227	0.58324	0.76251	0.029336	0.080918	26	-0.26162	0.11819	0.28494	26	1.34	0.075959	0.2801
"70"	"Regulation of actin cytoskeleton"	207	-1.6294	0.8912	1	1.6294	0.1088	0.39145	0.41863	0.001957	0.01178	105	-1.7524	0.11364	0.27611	102	2.3744	0.0043352	0.06621
"71"	"Ras signaling pathway"	218	-0.89527	0.65579	1	0.89527	0.34421	0.66918	1.6735	5.6362e-05	0.001357	108	0.39818	0.00036785	0.0052001	110	1.9613	0.012822	0.11456
"72"	"Rap1 signaling pathway"	206	-4.1247	0.99996	1	4.1247	3.6189e-05	0.0025412	2.2695	3.1631e-06	0.00099006	85	-0.6789	0.029176	0.1229	121	3.5302	9.6499e-05	0.019539
"73"	"RNA transport"	161	3.2595	7.1126e-05	0.011131	-3.2595	0.99993	1	-0.97199	0.062354	0.14041	92	0.94304	0.00020542	0.0035492	68	-1.597	0.84601	0.97473
"74"	"RNA polymerase"	28	-0.82068	0.75611	1	0.82068	0.24389	0.58324	-0.6582	0.34762	0.50175	12	-1.3551	0.63118	0.8027	16	0.30287	0.35015	0.61592
"75"	"RNA degradation"	75	2.6832	0.0011221	0.045277	-2.6832	0.99888	1	-2.9588	0.77628	0.87156	49	-1.4908	0.30397	0.47745	26	-2.9786	0.9913	1
"76"	"RIG-I-like receptor signaling pathway"	54	0.32617	0.27869	1	-0.32617	0.72131	0.96353	0.64353	0.038266	0.094308	30	-0.06767	0.075344	0.20733	24	1.0409	0.12437	0.34572
"77"	"Pyruvate metabolism"	36	0.1605	0.36785	1	-0.1605	0.63215	0.9263	0.51528	0.070975	0.15427	19	0.28248	0.08239	0.22281	17	0.45121	0.30729	0.58786
"78"	"Pyrimidine metabolism"	100	-3.2064	0.9982	1	3.2064	0.0018007	0.037575	-0.49173	0.075759	0.15808	37	-2.1769	0.64887	0.8072	63	1.0488	0.082569	0.28297
"79"	"Purine metabolism"	173	-1.9743	0.95006	1	1.9743	0.049942	0.27914	-0.11972	0.010209	0.038497	80	-1.7744	0.18361	0.36783	93	1.4824	0.034428	0.1941
"80"	"Proximal tubule bicarbonate reclamation"	21	0.2902	0.32808	1	-0.2902	0.67192	0.93983	-0.089804	0.2128	0.36003	11	0.054717	0.19206	0.37573	10	-0.18753	0.50094	0.75119
"81"	"Proteoglycans in cancer"	197	-0.739	0.64853	1	0.739	0.35147	0.6749	2.0703	1.0179e-05	0.0010011	97	0.66312	0.00072517	0.0090211	100	2.2526	0.0076566	0.086604
"82"	"Protein processing in endoplasmic reticulum"	157	4.0736	1.5469e-06	0.00048419	-4.0736	1	1	0.1595	0.009865	0.037655	105	0.9249	0.00016709	0.0032478	52	-1.0371	0.73147	0.90273
"83"	"Protein export"	25	1.5391	0.042748	0.42791	-1.5391	0.95725	1	-1.9893	0.76468	0.8672	20	-1.9753	0.72644	0.86961	5	-0.49748	0.63281	0.84707
"84"	"Protein digestion and absorption"	85	-0.38568	0.51165	1	0.38568	0.48835	0.81739	-2.0716	0.52697	0.66508	44	-2.2898	0.62182	0.80243	41	-0.6107	0.60265	0.82961
"85"	"Proteasome"	45	2.7689	0.0010221	0.045277	-2.7689	0.99898	1	-2.5075	0.77745	0.87156	30	0.21596	0.045627	0.16481	15	-4.6485	0.99995	1
"86"	"Prostate cancer"	85	-0.58193	0.58686	1	0.58193	0.41314	0.73473	-0.59897	0.12815	0.24339	40	-0.91178	0.17695	0.36205	45	0.036429	0.35436	0.61592
"87"	"Propanoate metabolism"	30	1.9683	0.015721	0.27228	-1.9683	0.98428	1	0.94786	0.035568	0.090509	21	0.66051	0.028664	0.1229	9	0.7216	0.21942	0.48449
"88"	"Prolactin signaling pathway"	67	-0.61405	0.67077	1	0.61405	0.32923	0.6562	0.67166	0.021349	0.063698	34	-0.13576	0.072363	0.20275	33	1.0948	0.10056	0.31911
"89"	"Progesterone-mediated oocyte maturation"	81	-0.71486	0.69599	1	0.71486	0.30401	0.63529	-1.0186	0.20553	0.35273	38	-1.085	0.24667	0.43846	43	-0.378	0.50316	0.75119
"90"	"Prion diseases"	33	-1.5872	0.92542	1	1.5872	0.074578	0.32804	-0.36111	0.231	0.38255	14	-0.96291	0.43098	0.6065	19	0.35066	0.29884	0.58453
"91"	"Primary immunodeficiency"	34	-3.2647	0.99925	1	3.2647	0.00075074	0.019582	0.89844	0.041472	0.099851	12	-1.9511	0.81386	0.93399	22	2.5579	0.0075303	0.086604
"92"	"Primary bile acid biosynthesis"	15	0.84941	0.15475	0.83985	-0.84941	0.84525	1	-0.091104	0.24982	0.3951	11	-0.40697	0.32304	0.4949	4	0.49847	0.28907	0.58
"93"	"Porphyrin and chlorophyll metabolism"	40	-0.013644	0.43444	1	0.013644	0.56556	0.87202	-4.6576	0.99556	1	20	-2.5021	0.86284	0.96342	19	-2.3074	0.96944	1
"94"	"Platinum drug resistance"	75	-2.4565	0.98649	1	2.4565	0.013513	0.12817	-2.0778	0.51876	0.66005	31	-3.1054	0.90831	0.97229	44	-0.10613	0.42282	0.68889
"95"	"Platelet activation"	119	-2.3155	0.97902	1	2.3155	0.020976	0.16414	1.5508	0.0006937	0.0062037	52	-0.2075	0.038067	0.14616	67	2.2496	0.0077971	0.086604
"96"	"Phototransduction"	25	-1.1843	0.85388	1	1.1843	0.14612	0.43984	-1.8543	0.72908	0.84152	11	-2.5435	0.9255	0.98322	14	-0.22341	0.50965	0.75119
"97"	"Phosphonate and phosphinate metabolism"	5	-1.1402	0.86035	1	1.1402	0.13965	0.43711	2.2107	0.015614	0.050909	1	1.9867	0.012451	0.064536	4	1.4783	0.076555	0.2801
"98"	"Phospholipase D signaling pathway"	141	-2.0748	0.95131	1	2.0748	0.048687	0.27795	0.7651	0.0024278	0.012988	69	-1.4175	0.17488	0.36205	72	2.4584	0.0065168	0.086604
"99"	"Phosphatidylinositol signaling system"	94	0.34874	0.27222	1	-0.34874	0.72778	0.96524	2.7549	4.288e-05	0.0013422	53	1.3473	0.00091863	0.0098515	41	2.6396	0.0043006	0.06621
"100"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	6	0.87279	0.16099	0.83985	-0.87279	0.83901	1	-1.687	0.82725	0.90534	5	-1.1803	0.67344	0.83017	1	-1.493	0.91538	1
"101"	"Phenylalanine metabolism"	21	-1.6321	0.93747	1	1.6321	0.062526	0.31565	1.6776	0.014162	0.04871	12	-0.736	0.40363	0.58386	9	3.4124	0.00088955	0.032233
"102"	"Phagosome"	161	-1.7703	0.93021	1	1.7703	0.069792	0.32804	-0.57179	0.031443	0.084117	68	-0.74298	0.053261	0.17076	93	-0.11701	0.35352	0.61592
"103"	"Pertussis"	71	-2.4164	0.98883	1	2.4164	0.011166	0.12052	-0.43639	0.1283	0.24339	32	-2.0518	0.63068	0.8027	39	1.2698	0.083154	0.28297
"104"	"Peroxisome"	82	0.3932	0.26218	1	-0.3932	0.73782	0.96626	-1.6971	0.39255	0.54367	45	-1.2791	0.25033	0.43846	37	-1.1158	0.74788	0.91563
"105"	"Pentose phosphate pathway"	29	0.78435	0.15584	0.83985	-0.78435	0.84416	1	-0.8844	0.41307	0.56214	17	-0.67926	0.31877	0.49078	12	-0.56637	0.64031	0.85029
"106"	"Pentose and glucuronate interconversions"	33	0.11575	0.37658	1	-0.11575	0.62342	0.9263	-5.6902	0.99963	1	18	-3.3501	0.98131	1	14	-2.7434	0.9877	1
"107"	"Pathways in cancer"	382	-2.7709	0.98914	1	2.7709	0.010855	0.12052	0.63386	1.9213e-05	0.0012028	170	-0.61589	0.0014519	0.012901	212	1.4024	0.033759	0.1941
"108"	"Parkinson disease"	123	0.049781	0.36076	1	-0.049781	0.63924	0.9263	-2.8164	0.55548	0.68228	70	-3.0437	0.70022	0.85065	53	-0.79262	0.64516	0.85029
"109"	"Pantothenate and CoA biosynthesis"	17	-0.69077	0.73305	1	0.69077	0.26695	0.61254	-0.7494	0.42874	0.57104	9	-1.6138	0.74561	0.88169	8	0.61927	0.25012	0.52559
"110"	"Pancreatic secretion"	93	1.5231	0.032354	0.37507	-1.5231	0.96765	1	-2.1248	0.48816	0.62878	58	-1.4851	0.23615	0.42699	34	-0.16658	0.44469	0.71288
"111"	"Pancreatic cancer"	63	-0.68232	0.70388	1	0.68232	0.29612	0.63051	1.6793	0.0024482	0.012988	32	0.43343	0.024084	0.107	31	1.9536	0.023949	0.16191
"112"	"PPAR signaling pathway"	79	-0.77774	0.70604	1	0.77774	0.29396	0.6302	-1.6176	0.35918	0.51102	37	-1.5201	0.41534	0.59623	42	-0.79175	0.65202	0.8556
"113"	"PI3K-Akt signaling pathway"	317	-1.6532	0.87328	1	1.6532	0.12672	0.42195	-0.43332	0.0020459	0.011914	145	-0.94974	0.0076027	0.046361	172	0.28374	0.17772	0.43867
"114"	"Oxytocin signaling pathway"	146	-0.65582	0.6253	1	0.65582	0.3747	0.70229	0.43997	0.0053031	0.023054	75	-0.2933	0.015152	0.07725	70	1.9202	0.016879	0.1346
"115"	"Oxidative phosphorylation"	113	0.4244	0.20882	1	-0.4244	0.79118	0.99056	-2.5906	0.55503	0.68228	60	-1.6421	0.25953	0.44388	53	-2.0355	0.93124	1
"116"	"Ovarian steroidogenesis"	52	-0.01156	0.41398	1	0.01156	0.58602	0.88611	0.76983	0.028958	0.080918	33	-1.1044	0.2916	0.47745	19	2.729	0.0037302	0.06445
"117"	"Other types of O-glycan biosynthesis"	21	-1.0928	0.83613	1	1.0928	0.16387	0.46209	-1.2471	0.5467	0.68174	9	-0.059371	0.22923	0.42356	11	0.80591	0.17308	0.43063
"118"	"Other glycan degradation"	15	-2.3415	0.99015	1	2.3415	0.0098542	0.11863	-1.2678	0.59955	0.72357	3	-1.4626	0.79921	0.92508	12	-0.68616	0.6796	0.86621
"119"	"Osteoclast differentiation"	120	-2.7059	0.99486	1	2.7059	0.005136	0.069894	2.1731	5.526e-05	0.001357	53	-0.12852	0.036298	0.14237	67	3.0226	0.00092963	0.032233
"120"	"Oocyte meiosis"	107	0.71084	0.14632	0.81781	-0.71084	0.85368	1	-0.19833	0.039074	0.095549	59	-0.003114	0.016029	0.078692	48	-0.29266	0.48822	0.75119
"121"	"One carbon pool by folate"	18	-1.3684	0.89985	1	1.3684	0.10015	0.37421	0.84693	0.07651	0.15859	9	-0.7125	0.43949	0.61293	9	1.9102	0.034951	0.1941
"122"	"Olfactory transduction"	656	0.39899	0.10897	0.72174	-0.39899	0.89103	1	-17.785	1	1	378	-14.777	1	1	278	-10.089	1	1
"123"	"Nucleotide excision repair"	42	-1.5033	0.90203	1	1.5033	0.097974	0.37421	0.24671	0.087912	0.17753	15	-0.040683	0.16317	0.34584	27	0.33802	0.29348	0.58453
"124"	"Notch signaling pathway"	48	-2.7148	0.99658	1	2.7148	0.003425	0.059557	1.1122	0.015309	0.050439	18	-0.54689	0.25976	0.44388	30	1.8304	0.021196	0.16004
"125"	"Non-small cell lung cancer"	57	-2.0943	0.97424	1	2.0943	0.02576	0.19665	1.8229	0.0026253	0.013471	23	0.37443	0.051383	0.17	34	2.0523	0.012821	0.11456
"126"	"Non-homologous end-joining"	11	-0.61398	0.71021	1	0.61398	0.28979	0.6267	-0.96789	0.56956	0.69366	3	-0.33422	0.41602	0.59623	8	-0.93028	0.7537	0.91563
"127"	"Non-alcoholic fatty liver disease (NAFLD)"	139	-0.98095	0.75865	1	0.98095	0.24135	0.58324	-1.6583	0.18951	0.33324	70	-2.1263	0.37053	0.55136	69	-0.21205	0.42016	0.68889
"128"	"Nitrogen metabolism"	16	-1.2118	0.86631	1	1.2118	0.13369	0.43143	-1.2042	0.59331	0.71979	6	-1.3761	0.727	0.86961	10	-0.45731	0.59496	0.82961
"129"	"Nicotine addiction"	35	0.30152	0.3214	1	-0.30152	0.6786	0.93983	-2.3074	0.78153	0.87156	21	-2.2512	0.78788	0.92117	14	-0.89111	0.73018	0.90273
"130"	"Nicotinate and nicotinamide metabolism"	32	0.168	0.34953	1	-0.168	0.65047	0.93393	-0.69963	0.30432	0.45186	18	-1.0029	0.42047	0.59984	14	0.0794	0.40401	0.68286
"131"	"Neurotrophin signaling pathway"	118	-1.1792	0.80226	1	1.1792	0.19774	0.53355	1.4349	0.00064876	0.0061534	57	0.28307	0.0085902	0.049473	61	1.7221	0.02915	0.18501
"132"	"Neuroactive ligand-receptor interaction"	238	-1.3686	0.83386	1	1.3686	0.16614	0.46384	-7.3977	0.9985	1	135	-8.423	1	1	103	-1.6021	0.81444	0.95222
"133"	"Neomycin, kanamycin and gentamicin biosynthesis"	4	-1.0731	0.85215	1	1.0731	0.14785	0.43984	0.76067	0.15698	0.28903	1	0.18846	0.3009	0.47745	3	0.76954	0.24	0.51123
"134"	"Natural killer cell mediated cytotoxicity"	99	-2.9174	0.99527	1	2.9174	0.0047263	0.068515	0.11584	0.036833	0.092974	41	-1.682	0.42567	0.60449	58	1.5655	0.0402	0.20495
"135"	"NOD-like receptor signaling pathway"	150	-0.75599	0.65993	1	0.75599	0.34007	0.66525	0.9165	0.0012445	0.0084682	70	0.38339	0.0037853	0.027378	80	0.89634	0.11217	0.33224
"136"	"NF-kappa B signaling pathway"	93	-0.080674	0.41473	1	0.080674	0.58527	0.88611	0.61816	0.015272	0.050439	44	1.0369	0.0029973	0.023901	49	-0.13092	0.4253	0.68889
"137"	"N-Glycan biosynthesis"	48	-0.48641	0.62937	1	0.48641	0.37063	0.69884	-1.9413	0.60105	0.72357	21	-0.26099	0.1477	0.32811	26	-0.79314	0.67351	0.86554
"138"	"Mucin type O-glycan biosynthesis"	26	1.8897	0.018329	0.28684	-1.8897	0.98167	1	0.79716	0.052586	0.12103	17	1.0701	0.020925	0.0986	9	-0.11584	0.48301	0.75119
"139"	"Morphine addiction"	87	-2.5504	0.98909	1	2.5504	0.010913	0.12052	-1.227	0.23393	0.38537	37	-2.8677	0.84355	0.95747	50	0.84841	0.13073	0.35664
"140"	"Mitophagy - animal"	61	2.1252	0.0080951	0.22714	-2.1252	0.9919	1	1.9808	0.0014179	0.0094424	36	2.2961	0.00017993	0.0032917	25	0.33873	0.3123	0.58786
"141"	"Mismatch repair"	21	-4.778	1	1	4.778	9.0807e-07	0.00028423	2.1892	0.0047031	0.02103	3	-1.7145	0.85847	0.96342	18	3.0646	0.0020264	0.057292
"142"	"Mineral absorption"	42	-0.073237	0.45197	1	0.073237	0.54803	0.86222	-0.55019	0.23782	0.38569	21	-0.55691	0.22007	0.4123	21	-0.22118	0.4993	0.75119
"143"	"MicroRNAs in cancer"	139	-1.8332	0.94463	1	1.8332	0.055371	0.28885	0.73599	0.0023582	0.01295	59	-0.17947	0.023945	0.107	80	1.1243	0.078405	0.28297
"144"	"Metabolism of xenobiotics by cytochrome P450"	63	-2.4182	0.99084	1	2.4182	0.0091628	0.11472	-4.2384	0.97389	1	25	-4.0291	0.98993	1	37	-0.86906	0.67776	0.86621
"145"	"Metabolic pathways"	1265	-1.7984	0.78205	1	1.7984	0.21795	0.55014	-5.4218	0.012158	0.044248	631	-5.6229	0.04018	0.15172	632	-1.399	0.53116	0.76833
"146"	"Melanoma"	67	-1.8995	0.96429	1	1.8995	0.035713	0.23255	-0.073581	0.074884	0.15808	28	-1.1218	0.33284	0.50741	39	0.85406	0.15413	0.4028
"147"	"Melanogenesis"	96	-0.10384	0.42982	1	0.10384	0.57018	0.87483	0.33289	0.019623	0.060813	53	-0.62464	0.088246	0.22905	43	1.1909	0.083494	0.28297
"148"	"Measles"	121	-2.0035	0.96232	1	2.0035	0.037679	0.23587	-0.83531	0.10583	0.20702	55	-2.0415	0.43922	0.61293	66	0.73261	0.16015	0.41449
"149"	"Maturity onset diabetes of the young"	19	-0.7574	0.72602	1	0.7574	0.27398	0.61254	-1.7846	0.73618	0.84152	10	-2.1354	0.87798	0.96342	9	-0.34204	0.56159	0.80117
"150"	"Mannose type O-glycan biosynthesis"	22	-1.0977	0.83841	1	1.0977	0.16159	0.45978	-1.2438	0.56614	0.69219	9	-0.89726	0.50575	0.68986	13	-0.8715	0.74333	0.91374
"151"	"Malaria"	46	-2.1248	0.97279	1	2.1248	0.027215	0.19878	-1.2501	0.39863	0.54965	14	-0.87823	0.40018	0.58157	32	-0.91795	0.69037	0.87351
"152"	"MAPK signaling pathway"	246	-0.77601	0.62051	1	0.77601	0.37949	0.70702	1.7327	1.2794e-05	0.0010011	126	0.6737	0.00012686	0.0028199	119	2.5506	0.0044708	0.06621
"153"	"Lysosome"	120	-1.5516	0.91129	1	1.5516	0.08871	0.3606	0.30896	0.0094027	0.037254	51	0.017913	0.023229	0.107	69	0.39205	0.22201	0.48449
"154"	"Lysine degradation"	56	1.4852	0.043567	0.42791	-1.4852	0.95643	1	-0.86235	0.24973	0.3951	36	-0.66386	0.16789	0.35043	20	-0.55232	0.61962	0.83981
"155"	"Lysine biosynthesis"	1	0.55157	0.27876	1	-0.55157	0.72124	0.96353	-0.20507	0.50988	0.6514	1	-0.20507	0.44229	0.61408	0	NA	NA	NA
"156"	"Longevity regulating pathway - multiple species"	60	0.78706	0.14429	0.81781	-0.78706	0.85571	1	2.1133	0.00097081	0.006906	32	1.6329	0.00099889	0.010021	28	1.348	0.073069	0.27379
"157"	"Longevity regulating pathway"	88	0.9704	0.10816	0.72174	-0.9704	0.89184	1	2.4716	0.00010259	0.0018888	46	2.1123	5.6715e-05	0.0028199	42	1.367	0.068245	0.25883
"158"	"Long-term potentiation"	63	2.515	0.0023799	0.082769	-2.515	0.99762	1	2.0107	0.001035	0.0071987	41	1.983	0.00022754	0.0037245	22	0.69543	0.21345	0.47757
"159"	"Long-term depression"	57	-0.37359	0.56864	1	0.37359	0.43136	0.75852	1.3439	0.0078682	0.031984	30	0.064431	0.060052	0.18438	27	1.8848	0.023481	0.16191
"160"	"Lipoic acid metabolism"	2	-1.2152	0.88282	1	1.2152	0.11718	0.40751	-0.078679	0.43607	0.57835	0	NA	NA	NA	2	-0.078679	0.47647	0.75119
"161"	"Linoleic acid metabolism"	46	-0.065575	0.41632	1	0.065575	0.58368	0.88611	-3.5619	0.93666	0.9838	26	-3.3478	0.95179	0.99666	20	-1.5847	0.88923	0.99575
"162"	"Leukocyte transendothelial migration"	107	-2.7869	0.99518	1	2.7869	0.0048158	0.068515	0.93273	0.0037617	0.017573	42	-0.49428	0.1	0.25081	65	1.594	0.038371	0.19996
"163"	"Leishmaniasis"	64	-4.0795	0.99997	1	4.0795	2.8636e-05	0.0025412	2.3856	0.00074224	0.006279	20	0.12303	0.087863	0.22905	44	2.7942	0.0027762	0.06445
"164"	"Legionellosis"	56	-0.28872	0.51444	1	0.28872	0.48556	0.81739	0.13841	0.072028	0.15548	31	-0.85004	0.24011	0.43165	25	1.1537	0.1095	0.33063
"165"	"Jak-STAT signaling pathway"	133	-1.6921	0.92645	1	1.6921	0.073547	0.32804	-1.3644	0.16546	0.29764	66	-2.7825	0.63544	0.8027	67	0.83933	0.12451	0.34572
"166"	"Intestinal immune network for IgA production"	40	-3.7777	0.99991	1	3.7777	9.4701e-05	0.0037052	1.1682	0.021255	0.063698	14	-1.8516	0.74391	0.88169	26	2.8077	0.0031856	0.06445
"167"	"Insulin signaling pathway"	136	0.29255	0.26371	1	-0.29255	0.73629	0.96626	1.9663	9.9513e-05	0.0018888	71	0.90821	0.00084265	0.0095669	65	1.895	0.021358	0.16004
"168"	"Insulin secretion"	80	0.87112	0.11484	0.72174	-0.87112	0.88516	1	0.3478	0.024013	0.068954	43	0.78372	0.0057024	0.037733	37	-0.33346	0.50532	0.75119
"169"	"Insulin resistance"	106	1.0866	0.059693	0.49168	-1.0866	0.94031	1	0.62493	0.0098476	0.037655	57	0.7723	0.0022778	0.018642	49	0.086187	0.35128	0.61592
"170"	"Inositol phosphate metabolism"	69	0.42248	0.24235	1	-0.42248	0.75765	0.97023	2.9911	2.7194e-05	0.0012235	36	2.4845	9.4344e-05	0.0028199	33	1.7301	0.031434	0.188
"171"	"Influenza A"	150	-2.4389	0.98501	1	2.4389	0.014987	0.13403	-0.38267	0.023372	0.067736	65	-1.93	0.31085	0.48097	85	1.1794	0.060552	0.24457
"172"	"Inflammatory mediator regulation of TRP channels"	118	-0.2721	0.47051	1	0.2721	0.52949	0.8508	-0.84273	0.089855	0.18029	62	-1.2722	0.16458	0.34584	56	0.1153	0.31576	0.58786
"173"	"Inflammatory bowel disease (IBD)"	55	-2.2323	0.98036	1	2.2323	0.019635	0.15758	0.52236	0.043881	0.10485	22	-0.66165	0.25899	0.44388	33	1.2146	0.08256	0.28297
"174"	"IL-17 signaling pathway"	84	1.2384	0.056067	0.49168	-1.2384	0.94393	1	-0.89037	0.19475	0.33864	47	-0.16019	0.040978	0.15172	37	-1.161	0.75982	0.9159
"175"	"Hypertrophic cardiomyopathy (HCM)"	81	1.9236	0.012822	0.27228	-1.9236	0.98718	1	1.7697	0.00091476	0.0066586	47	2.0601	8.4505e-05	0.0028199	33	1.7431	0.030607	0.18664
"176"	"Huntingtons disease"	178	0.020192	0.33336	1	-0.020192	0.66664	0.93983	-2.7346	0.42094	0.56546	95	-2.5237	0.35995	0.539	83	-1.3047	0.76801	0.91865
"177"	"Homologous recombination"	37	-1.5218	0.92246	1	1.5218	0.077536	0.32804	-0.18121	0.17502	0.31126	14	-0.59383	0.30213	0.47745	23	0.23346	0.34353	0.614
"178"	"Histidine metabolism"	24	0.38838	0.27789	1	-0.38838	0.72211	0.96353	-1.2608	0.55362	0.68228	15	-1.4048	0.60271	0.78757	9	-0.24533	0.52811	0.76749
"179"	"Hippo signaling pathway -multiple species"	25	0.30182	0.32279	1	-0.30182	0.67721	0.93983	1.0806	0.034897	0.089531	13	0.8595	0.036398	0.14237	12	0.66508	0.2286	0.49217
"180"	"Hippo signaling pathway"	150	0.71361	0.13071	0.79182	-0.71361	0.86929	1	1.0667	0.00083196	0.0065101	78	0.94218	0.00052244	0.0067699	72	0.55903	0.19618	0.45673
"181"	"Herpes simplex infection"	184	-0.92067	0.70968	1	0.92067	0.29032	0.6267	-2.8582	0.42029	0.56546	83	-1.2368	0.08838	0.22905	100	-1.9293	0.90031	1
"182"	"Hepatitis C"	116	-0.86272	0.71609	1	0.86272	0.28391	0.62581	-0.38496	0.050996	0.11823	57	-1.3602	0.19552	0.37769	59	0.79713	0.14446	0.38398
"183"	"Hepatitis B"	130	-0.39068	0.52303	1	0.39068	0.47697	0.8158	1.3176	0.0008172	0.0065101	65	0.36777	0.0045571	0.03221	65	1.4956	0.045902	0.2054
"184"	"Hematopoietic cell lineage"	88	-3.3388	0.99947	1	3.3388	0.00053019	0.016595	1.0409	0.0051371	0.022647	34	-0.90506	0.23153	0.42356	54	2.0469	0.013027	0.11456
"185"	"Hedgehog signaling pathway"	43	-1.3975	0.89996	1	1.3975	0.10004	0.37421	0.33929	0.078418	0.16042	19	-0.69224	0.29868	0.47745	24	1.0701	0.11913	0.33682
"186"	"HTLV-I infection"	264	-1.7965	0.91561	1	1.7965	0.084385	0.34753	0.81228	0.00017459	0.0027323	121	0.0075105	0.0015573	0.013454	143	1.0968	0.061389	0.24477
"187"	"HIF-1 signaling pathway"	98	1.3447	0.045676	0.43323	-1.3447	0.95432	1	0.82755	0.0078438	0.031984	51	1.8466	0.00012396	0.0028199	47	-0.72856	0.6068	0.83134
"188"	"Graft-versus-host disease"	49	-2.2341	0.98296	1	2.2341	0.017044	0.14419	-3.4196	0.92818	0.98091	15	-2.4146	0.88093	0.96342	34	-2.5014	0.98043	1
"189"	"GnRH signaling pathway"	85	0.28844	0.2662	1	-0.28844	0.7338	0.96626	2.0467	0.00049022	0.0051147	46	1.2546	0.0010988	0.010158	39	1.6589	0.042164	0.20533
"190"	"Glyoxylate and dicarboxylate metabolism"	28	0.03547	0.43677	1	-0.03547	0.56323	0.87202	-0.87246	0.41261	0.56214	14	-0.56373	0.29241	0.47745	14	-0.67012	0.66216	0.85804
"191"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	23	-1.1182	0.86224	1	1.1182	0.13776	0.43555	-0.026449	0.2053	0.35273	11	-1.301	0.63188	0.8027	12	1.209	0.10924	0.33063
"192"	"Glycosphingolipid biosynthesis - lacto and neolacto series"	26	-0.12585	0.49113	1	0.12585	0.50887	0.83994	-1.1096	0.47005	0.61303	11	-0.25978	0.2775	0.46151	15	-1.2384	0.81273	0.95222
"193"	"Glycosphingolipid biosynthesis - globo and isoglobo series"	15	-1.2437	0.88099	1	1.2437	0.11901	0.40933	-1.3518	0.62488	0.74368	3	0.012782	0.29623	0.47745	12	-1.5177	0.88709	0.99575
"194"	"Glycosphingolipid biosynthesis - ganglio series"	14	-0.37648	0.60517	1	0.37648	0.39483	0.7227	0.044313	0.23601	0.38569	7	-0.34076	0.34721	0.52419	7	0.40342	0.30549	0.58786
"195"	"Glycosaminoglycan degradation"	18	-0.36971	0.61803	1	0.36971	0.38197	0.70744	-1.939	0.78803	0.87156	8	-1.6258	0.77882	0.91401	10	-1.1473	0.80204	0.94483
"196"	"Glycosaminoglycan biosynthesis - keratan sulfate"	12	-0.84845	0.77653	1	0.84845	0.22347	0.55957	0.057923	0.25496	0.39902	4	0.32679	0.19533	0.37769	8	-0.16013	0.50403	0.75119
"197"	"Glycosaminoglycan biosynthesis - heparan sulfate / heparin"	23	-1.3966	0.91699	1	1.3966	0.083009	0.34643	-1.7845	0.71372	0.83046	9	-2.2429	0.8903	0.96813	14	-0.48903	0.60202	0.82961
"198"	"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate"	19	-0.84313	0.75403	1	0.84313	0.24597	0.58324	1.3076	0.025913	0.073071	8	0.91328	0.057157	0.17776	11	0.93968	0.14276	0.38273
"199"	"Glycolysis / Gluconeogenesis"	62	-1.7104	0.92792	1	1.7104	0.072077	0.32804	-0.052471	0.082822	0.16833	24	-0.72283	0.25081	0.43846	38	0.50743	0.22947	0.49217
"200"	"Glycine, serine and threonine metabolism"	39	0.35963	0.27658	1	-0.35963	0.72342	0.96353	0.65611	0.049219	0.11497	24	-0.46358	0.18278	0.36783	15	1.6443	0.050565	0.21415
"201"	"Glycerophospholipid metabolism"	90	-1.0906	0.78681	1	1.0906	0.21319	0.54695	0.39896	0.024377	0.069363	49	-2.055	0.5116	0.69178	41	2.8376	0.0025278	0.06445
"202"	"Glycerolipid metabolism"	56	-0.64806	0.65175	1	0.64806	0.34825	0.67285	-2.5294	0.73667	0.84152	32	-3.7524	0.97219	1	24	0.46928	0.25937	0.53776
"203"	"Glutathione metabolism"	55	-1.7742	0.94475	1	1.7742	0.055253	0.28885	-1.8249	0.54438	0.68157	23	-2.6793	0.89603	0.96815	32	-0.1209	0.42364	0.68889
"204"	"Glutamatergic synapse"	110	0.37311	0.24237	1	-0.37311	0.75763	0.97023	-0.056852	0.030858	0.083264	61	-0.63257	0.050069	0.16926	49	0.62061	0.1954	0.45673
"205"	"Glucagon signaling pathway"	95	1.8199	0.015862	0.27228	-1.8199	0.98414	1	2.6412	3.7003e-05	0.0013422	56	2.097	4.1142e-05	0.0028199	39	1.6093	0.046232	0.2054
"206"	"Glioma"	62	-1.7595	0.93447	1	1.7595	0.065528	0.32047	1.7863	0.0023107	0.012915	27	0.30025	0.046104	0.16481	35	2.1138	0.015629	0.12791
"207"	"Gastric acid secretion"	70	-0.1413	0.44906	1	0.1413	0.55094	0.86222	0.96629	0.0091066	0.036543	40	-0.60933	0.11223	0.27482	30	2.1796	0.009253	0.09923
"208"	"Gap junction"	84	-0.76298	0.70135	1	0.76298	0.29865	0.6316	0.44503	0.029472	0.080918	40	-0.13419	0.047779	0.16589	44	0.74284	0.1712	0.43063
"209"	"Galactose metabolism"	31	-1.2319	0.86757	1	1.2319	0.13243	0.43143	-1.2073	0.4744	0.61614	13	-2.0732	0.82536	0.94093	18	0.17755	0.3545	0.61592
"210"	"GABAergic synapse"	83	-0.88244	0.75531	1	0.88244	0.24469	0.58324	-1.485	0.30076	0.45186	42	-2.2434	0.63268	0.8027	41	0.15777	0.33631	0.6081
"211"	"Fructose and mannose metabolism"	34	-1.8634	0.95671	1	1.8634	0.043293	0.26059	1.0411	0.032468	0.085399	13	-0.34376	0.25016	0.43846	21	1.5952	0.050956	0.21415
"212"	"FoxO signaling pathway"	128	1.5438	0.02324	0.30566	-1.5438	0.97676	1	0.82636	0.0031951	0.01536	75	0.42475	0.0022561	0.018642	53	0.77893	0.15038	0.39634
"213"	"Folate biosynthesis"	12	0.21401	0.366	1	-0.21401	0.634	0.9263	-2.1449	0.85734	0.92297	6	-1.2889	0.69984	0.85065	6	-1.7444	0.92418	1
"214"	"Focal adhesion"	196	-1.1494	0.78356	1	1.1494	0.21644	0.55014	1.3646	0.00014995	0.0024702	85	1.1809	0.00013921	0.0028862	111	0.77995	0.11366	0.33348
"215"	"Fluid shear stress and atherosclerosis"	138	-1.9647	0.95116	1	1.9647	0.04884	0.27795	0.4423	0.0041954	0.019311	56	0.13784	0.01591	0.078692	82	0.45987	0.20265	0.46341
"216"	"Ferroptosis"	38	-0.3843	0.59507	1	0.3843	0.40493	0.73473	0.081909	0.12656	0.24302	17	0.082637	0.12461	0.29583	21	0.035832	0.4079	0.68571
"217"	"Fc gamma R-mediated phagocytosis"	84	-3.2892	0.99931	1	3.2892	0.00068622	0.019526	1.8077	0.0016535	0.010562	35	-1.1341	0.26757	0.4531	49	3.3253	0.00054001	0.032233
"218"	"Fc epsilon RI signaling pathway"	63	-2.2787	0.98653	1	2.2787	0.013468	0.12817	2.4936	0.0002621	0.0031552	30	-0.14312	0.085321	0.22679	33	3.5819	0.00018848	0.019539
"219"	"Fatty acid metabolism"	51	-1.2732	0.8663	1	1.2732	0.1337	0.43143	-0.7987	0.24254	0.3893	22	-1.0647	0.39132	0.57406	29	-0.13187	0.42138	0.68889
"220"	"Fatty acid elongation"	26	-1.2773	0.87673	1	1.2773	0.12327	0.41938	-1.6538	0.64276	0.76206	12	-2.3994	0.90515	0.97229	14	-0.032406	0.44262	0.71288
"221"	"Fatty acid degradation"	47	0.49004	0.22511	1	-0.49004	0.77489	0.97799	-0.72214	0.25333	0.39845	26	-0.34132	0.13337	0.30726	21	-0.70056	0.66621	0.85971
"222"	"Fatty acid biosynthesis"	12	-2.2941	0.98813	1	2.2941	0.01187	0.12384	0.59183	0.1406	0.26195	3	-1.0242	0.6666	0.82594	9	1.2747	0.10431	0.32441
"223"	"Fat digestion and absorption"	36	0.85751	0.14265	0.81781	-0.85751	0.85735	1	-5.1335	0.99908	1	23	-4.1459	0.99595	1	13	-3.0281	0.99523	1
"224"	"Fanconi anemia pathway"	48	-2.2541	0.98656	1	2.2541	0.013439	0.12817	-0.76598	0.24994	0.3951	17	-1.804	0.70345	0.85125	31	0.38279	0.28218	0.57736
"225"	"Ether lipid metabolism"	41	-0.8161	0.72295	1	0.8161	0.27705	0.61502	0.77882	0.039522	0.095894	20	-0.55416	0.23492	0.42699	21	1.629	0.047845	0.20957
"226"	"Estrogen signaling pathway"	94	0.19701	0.32708	1	-0.19701	0.67292	0.93983	-0.96949	0.15865	0.2898	50	-1.0056	0.15883	0.34584	44	-0.34502	0.50705	0.75119
"227"	"ErbB signaling pathway"	84	0.41077	0.23785	1	-0.41077	0.76215	0.97023	2.5015	0.00025848	0.0031552	45	1.7072	0.00026624	0.00414	39	1.8373	0.029859	0.18572
"228"	"Epstein-Barr virus infection"	199	-0.092219	0.37497	1	0.092219	0.62503	0.9263	-0.53436	0.014047	0.04871	101	-0.53377	0.012146	0.064022	98	-0.21959	0.39217	0.66742
"229"	"Endometrial cancer"	49	-0.56654	0.63978	1	0.56654	0.36022	0.68749	0.95243	0.019252	0.060258	23	0.59142	0.033105	0.13728	26	0.75126	0.18055	0.43878
"230"	"Endocytosis"	267	-0.71938	0.60528	1	0.71938	0.39472	0.7227	0.98029	0.00012838	0.0022324	133	0.023769	0.00086132	0.0095669	134	1.3601	0.042472	0.20533
"231"	"Endocrine resistance"	92	-1.1052	0.79375	1	1.1052	0.20625	0.54249	1.4152	0.0018431	0.011538	41	0.88167	0.006059	0.039258	51	1.1103	0.085529	0.28297
"232"	"Endocrine and other factor-regulated calcium reabsorption"	48	0.9946	0.10611	0.72174	-0.9946	0.89389	1	0.3539	0.059199	0.13427	30	-0.19989	0.093457	0.23824	18	0.83598	0.1727	0.43063
"233"	"EGFR tyrosine kinase inhibitor resistance"	78	-1.2135	0.83967	1	1.2135	0.16033	0.45978	2.2604	0.00037576	0.0042004	33	1.6499	0.0011105	0.010158	45	1.5631	0.037247	0.19972
"234"	"ECM-receptor interaction"	82	-1.054	0.78882	1	1.054	0.21118	0.54695	-0.19362	0.069309	0.1517	34	-0.043681	0.061156	0.18466	48	-0.21631	0.46081	0.73118
"235"	"Drug metabolism - other enzymes"	49	-0.67945	0.68336	1	0.67945	0.31664	0.64776	-3.8926	0.96745	1	26	-3.1517	0.93077	0.98339	22	-0.63277	0.64524	0.85029
"236"	"Drug metabolism - cytochrome P450"	64	-1.2009	0.84964	1	1.2009	0.15036	0.43984	-4.0727	0.95041	0.99491	34	-3.881	0.98074	1	29	-0.32341	0.48786	0.75119
"237"	"Dorso-ventral axis formation"	25	1.0276	0.11529	0.72174	-1.0276	0.88471	1	0.63265	0.074454	0.15808	16	0.5114	0.060471	0.18438	9	0.37255	0.31945	0.58786
"238"	"Dopaminergic synapse"	125	1.3101	0.035364	0.39531	-1.3101	0.96464	1	-0.28596	0.029835	0.081203	70	0.26864	0.0051791	0.035793	55	-0.73417	0.61683	0.83981
"239"	"Dilated cardiomyopathy"	86	1.7159	0.016177	0.27228	-1.7159	0.98382	1	1.8419	0.00062983	0.0061534	49	2.0727	4.1191e-05	0.0028199	36	1.797	0.028476	0.1845
"240"	"DNA replication"	34	-3.6624	0.99983	1	3.6624	0.000166	0.0057729	2.2653	0.0025108	0.013098	7	0.69619	0.095572	0.24165	27	2.1876	0.011627	0.11456
"241"	"D-Glutamine and D-glutamate metabolism"	2	-0.5346	0.68859	1	0.5346	0.31141	0.64551	0.70127	0.20825	0.35426	1	-0.01916	0.37331	0.55286	1	1.0109	0.18059	0.43878
"242"	"D-Arginine and D-ornithine metabolism"	1	0.073791	0.45763	1	-0.073791	0.54237	0.86173	-1.5647	0.86135	0.92297	1	-1.5647	0.8762	0.96342	0	NA	NA	NA
"243"	"Cytosolic DNA-sensing pathway"	49	-1.9263	0.96359	1	1.9263	0.036406	0.23255	-0.43754	0.17193	0.3075	21	-2.3269	0.80765	0.93029	28	1.4364	0.062767	0.2471
"244"	"Cytokine-cytokine receptor interaction"	234	-3.1948	0.99756	1	3.1948	0.002439	0.044907	-2.4786	0.22414	0.37316	104	-3.359	0.61307	0.79443	129	0.40051	0.19023	0.45161
"245"	"Cysteine and methionine metabolism"	45	1.1799	0.078215	0.58289	-1.1799	0.92178	1	-1.4177	0.4613	0.60413	28	-1.0323	0.30382	0.47745	17	-0.98179	0.77876	0.92441
"246"	"Complement and coagulation cascades"	85	-1.1323	0.77429	1	1.1323	0.22571	0.56068	-3.2696	0.85224	0.92297	44	-3.4092	0.90976	0.97229	41	-1.176	0.7771	0.92441
"247"	"Colorectal cancer"	59	-1.9793	0.96047	1	1.9793	0.039527	0.24259	0.71076	0.023254	0.067736	25	-0.62512	0.21806	0.41101	34	1.4723	0.046031	0.2054
"248"	"Collecting duct acid secretion"	25	-0.11897	0.48745	1	0.11897	0.51255	0.83994	0.69034	0.067976	0.14983	13	0.1448	0.12949	0.30509	12	0.84571	0.18268	0.44041
"249"	"Cocaine addiction"	46	1.3879	0.042896	0.42791	-1.3879	0.9571	1	-0.5211	0.20623	0.35273	27	0.041974	0.074604	0.20716	19	-0.86086	0.71442	0.8959
"250"	"Citrate cycle (TCA cycle)"	29	1.5667	0.031394	0.37507	-1.5667	0.96861	1	-2.1815	0.78739	0.87156	16	-0.33912	0.22419	0.4175	13	-2.882	0.99307	1
"251"	"Circadian rhythm"	29	0.58536	0.21309	1	-0.58536	0.78691	0.98917	3.1183	0.00039232	0.0042343	16	2.1448	0.0010589	0.010158	13	2.278	0.014718	0.12371
"252"	"Circadian entrainment"	94	-0.35888	0.55225	1	0.35888	0.44775	0.77859	-0.33771	0.067241	0.14927	48	-0.60094	0.084703	0.22679	46	0.13111	0.31934	0.58786
"253"	"Chronic myeloid leukemia"	70	-0.87622	0.73232	1	0.87622	0.26768	0.61254	0.31312	0.033537	0.086751	36	-0.99452	0.25095	0.43846	34	1.4726	0.046002	0.2054
"254"	"Cholinergic synapse"	108	-0.90753	0.73104	1	0.90753	0.26896	0.61254	0.235	0.017954	0.056765	56	-1.1249	0.16053	0.34584	52	1.5061	0.053268	0.22088
"255"	"Choline metabolism in cancer"	96	-0.86016	0.72914	1	0.86016	0.27086	0.61254	1.2161	0.0027654	0.013937	48	0.055568	0.023563	0.107	48	1.6642	0.036345	0.1983
"256"	"Chemokine signaling pathway"	178	-4.2106	0.99996	1	4.2106	4.0595e-05	0.0025412	1.4827	0.0002215	0.0031513	71	-0.98087	0.075999	0.20733	106	3.5215	0.00015102	0.019539
"257"	"Chemical carcinogenesis"	90	-1.3338	0.85166	1	1.3338	0.14834	0.43984	-5.8679	0.99815	1	38	-3.8507	0.96668	1	51	-3.3216	0.9948	1
"258"	"Chagas disease (American trypanosomiasis)"	99	-1.2897	0.83254	1	1.2897	0.16746	0.46384	-0.48553	0.094141	0.18768	49	-1.5087	0.31	0.48097	50	0.81032	0.13824	0.37385
"259"	"Central carbon metabolism in cancer"	61	-3.0414	0.99861	1	3.0414	0.0013917	0.031114	1.6734	0.0030423	0.014879	19	0.57531	0.049693	0.16926	42	1.6298	0.042915	0.20533
"260"	"Cell cycle"	119	-1.5907	0.90371	1	1.5907	0.09629	0.37421	0.25954	0.014946	0.050304	50	-0.063739	0.029244	0.1229	69	0.3951	0.22117	0.48449
"261"	"Cell adhesion molecules (CAMs)"	147	-4.0525	0.99992	1	4.0525	8.1788e-05	0.0036571	-2.7834	0.52557	0.66508	53	-3.7558	0.92631	0.98322	94	-0.66062	0.5657	0.80335
"262"	"Cardiac muscle contraction"	71	1.8724	0.012744	0.27228	-1.8724	0.98726	1	0.46295	0.033105	0.086348	36	2.5807	6.7156e-05	0.0028199	34	-0.57862	0.59851	0.82961
"263"	"Carbon metabolism"	111	1.2447	0.059301	0.49168	-1.2447	0.9407	1	-0.22327	0.037533	0.093983	60	0.36647	0.0053769	0.036352	51	-0.72689	0.60287	0.82961
"264"	"Carbohydrate digestion and absorption"	42	-1.2201	0.84452	1	1.2201	0.15548	0.45061	-1.287	0.45177	0.59413	18	-1.3455	0.55268	0.7377	24	-0.53735	0.5985	0.82961
"265"	"Calcium signaling pathway"	173	-1.1894	0.79832	1	1.1894	0.20168	0.53806	-1.0062	0.053791	0.1229	84	-1.6453	0.16316	0.34584	89	0.19557	0.29742	0.58453
"266"	"Caffeine metabolism"	4	0.73288	0.19795	1	-0.73288	0.80205	0.99226	-1.7549	0.86399	0.92297	3	-0.97035	0.64817	0.8072	1	-1.8292	0.9537	1
"267"	"Butanoate metabolism"	25	0.67012	0.20189	1	-0.67012	0.79811	0.99154	-1.8714	0.73373	0.84152	12	-0.066261	0.19209	0.37573	13	-2.5315	0.98406	1
"268"	"Breast cancer"	141	-1.2449	0.79715	1	1.2449	0.20285	0.53806	0.014851	0.013512	0.048611	66	-0.69373	0.056418	0.17723	75	0.67114	0.16746	0.42688
"269"	"Bladder cancer"	37	-3.8243	0.99994	1	3.8243	5.8731e-05	0.0030638	2.7528	0.0006864	0.0062037	11	0.11965	0.17667	0.36205	26	3.2061	0.0010364	0.032233
"270"	"Biotin metabolism"	2	-1.0923	0.85619	1	1.0923	0.14381	0.43984	0.16186	0.35872	0.51102	0	NA	NA	NA	2	0.16186	0.39273	0.66742
"271"	"Biosynthesis of unsaturated fatty acids"	27	-2.1398	0.98144	1	2.1398	0.018563	0.1529	-1.5178	0.60477	0.72526	10	-2.4897	0.93326	0.98339	17	-0.0033593	0.4601	0.73118
"272"	"Biosynthesis of amino acids"	73	1.8695	0.016528	0.27228	-1.8695	0.98347	1	-1.2728	0.27401	0.42249	44	-0.2818	0.062294	0.18628	29	-1.6723	0.87536	0.99575
"273"	"Bile secretion"	68	-0.39105	0.54364	1	0.39105	0.45636	0.78596	-2.5298	0.70789	0.82675	36	-3.1913	0.89655	0.96815	32	-0.30284	0.48596	0.75119
"274"	"Base excision repair"	32	-2.0088	0.97269	1	2.0088	0.027309	0.19878	0.77416	0.048641	0.11468	9	0.26955	0.14962	0.33001	23	0.74453	0.19685	0.45673
"275"	"Basal transcription factors"	41	1.225	0.065243	0.52362	-1.225	0.93476	1	-2.2277	0.72415	0.83948	21	-0.20823	0.1367	0.3085	20	-2.9762	0.99305	1
"276"	"Basal cell carcinoma"	53	-1.7834	0.9448	1	1.7834	0.055198	0.28885	-0.071515	0.10081	0.19892	23	-1.3936	0.51679	0.69276	30	1.1252	0.085041	0.28297
"277"	"Bacterial invasion of epithelial cells"	66	-1.6461	0.93579	1	1.6461	0.064205	0.31899	2.1448	0.00072477	0.006279	33	-0.050243	0.065587	0.19243	33	3.0835	0.0009697	0.032233
"278"	"B cell receptor signaling pathway"	68	-2.0538	0.96482	1	2.0538	0.035181	0.23255	1.9882	0.00087008	0.0066121	30	-0.030061	0.070716	0.20177	38	2.6864	0.0037078	0.06445
"279"	"Axon guidance"	171	-1.6257	0.89364	1	1.6257	0.10636	0.38711	1.3388	0.0002602	0.0031552	81	-0.047051	0.0084074	0.049334	90	1.89	0.013261	0.11456
"280"	"Autophagy - other"	30	0.20165	0.36137	1	-0.20165	0.63863	0.9263	-0.89064	0.38511	0.53947	17	-0.73864	0.33795	0.5127	13	-0.50831	0.62823	0.84579
"281"	"Autophagy - animal"	126	0.70156	0.13565	0.80108	-0.70156	0.86435	1	2.296	4.9436e-05	0.001357	69	1.4939	0.00012694	0.0028199	57	1.77	0.023334	0.16191
"282"	"Autoimmune thyroid disease"	50	-1.6209	0.92892	1	1.6209	0.071082	0.32804	-3.029	0.86296	0.92297	20	-2.5713	0.8765	0.96342	30	-1.811	0.91409	1
"283"	"Asthma"	19	-3.0123	0.99797	1	3.0123	0.0020311	0.039734	0.9628	0.048729	0.11468	7	-1.7414	0.80015	0.92508	12	2.5415	0.0076801	0.086604
"284"	"Ascorbate and aldarate metabolism"	26	0.66711	0.2017	1	-0.66711	0.7983	0.99154	-6.3461	0.99998	1	16	-3.4222	0.9828	1	9	-3.4869	0.99815	1
"285"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	70	-0.93665	0.75217	1	0.93665	0.24783	0.58324	-1.3109	0.30388	0.45186	33	-1.0381	0.2712	0.45591	36	0.53421	0.22277	0.48449
"286"	"Arginine biosynthesis"	18	1.6768	0.043748	0.42791	-1.6768	0.95625	1	-0.41053	0.33612	0.49161	13	0.13299	0.13182	0.30726	5	-0.99337	0.78701	0.93065
"287"	"Arginine and proline metabolism"	47	0.27978	0.29778	1	-0.27978	0.70222	0.96196	-0.91844	0.30461	0.45186	25	-0.80079	0.26807	0.4531	22	-0.48878	0.59715	0.82961
"288"	"Arachidonic acid metabolism"	83	-0.43737	0.59081	1	0.43737	0.40919	0.73473	-4.0459	0.93077	0.98091	41	-3.2027	0.88288	0.96342	42	-2.5233	0.97119	1
"289"	"Apoptosis - multiple species"	30	0.085305	0.40653	1	-0.085305	0.59347	0.88879	-0.65133	0.31243	0.46128	16	-0.58681	0.299	0.47745	14	-0.32613	0.54571	0.7821
"290"	"Apoptosis"	132	-1.7123	0.92671	1	1.7123	0.073294	0.32804	0.26541	0.011002	0.040515	60	-0.74531	0.067367	0.19545	72	1.0397	0.10253	0.32209
"291"	"Apelin signaling pathway"	136	-0.56154	0.59245	1	0.56154	0.40755	0.73473	2.6075	1.134e-05	0.0010011	69	1.1205	0.00046807	0.0063291	67	2.5778	0.0033364	0.06445
"292"	"Antigen processing and presentation"	71	-1.768	0.94536	1	1.768	0.054638	0.28885	-1.4233	0.35812	0.51102	31	-1.6591	0.50978	0.69178	40	-0.43571	0.52629	0.76749
"293"	"Antifolate resistance"	29	-1.354	0.90469	1	1.354	0.095307	0.37421	-0.36568	0.26553	0.41349	15	-1.4022	0.60181	0.78757	14	0.92517	0.16127	0.41449
"294"	"Amyotrophic lateral sclerosis (ALS)"	50	0.37781	0.27947	1	-0.37781	0.72053	0.96353	-0.40082	0.16018	0.2898	24	0.42562	0.044223	0.16181	26	-0.96476	0.72611	0.90273
"295"	"Amphetamine addiction"	63	1.6665	0.026706	0.33436	-1.6665	0.97329	1	0.83965	0.016216	0.052327	36	1.3325	0.0032666	0.02499	27	-0.25608	0.50445	0.75119
"296"	"Amoebiasis"	94	-0.90486	0.75814	1	0.90486	0.24186	0.58324	0.55906	0.013847	0.04871	45	-0.2829	0.05432	0.17238	49	1.0454	0.10808	0.33063
"297"	"Aminoacyl-tRNA biosynthesis"	43	0.35428	0.2962	1	-0.35428	0.7038	0.96196	-0.43851	0.21658	0.3625	27	-1.7742	0.60106	0.78757	16	1.5859	0.067702	0.25883
"298"	"Amino sugar and nucleotide sugar metabolism"	48	-1.7479	0.95294	1	1.7479	0.047061	0.27793	-1.2441	0.38359	0.53947	20	-2.336	0.82596	0.94093	28	0.34539	0.28725	0.58
"299"	"Alzheimers disease"	160	-0.60445	0.57852	1	0.60445	0.42148	0.74533	-1.5207	0.13185	0.24861	82	-1.696	0.18413	0.36783	78	-0.43897	0.49039	0.75119
"300"	"Allograft rejection"	47	-1.9624	0.96859	1	1.9624	0.031411	0.21373	-2.8893	0.84696	0.92297	17	-2.4246	0.86195	0.96342	30	-1.7912	0.91116	1
"301"	"Aldosterone-regulated sodium reabsorption"	36	0.98688	0.11426	0.72174	-0.98688	0.88574	1	-0.55413	0.27389	0.42249	21	-0.046603	0.10654	0.26326	15	-0.80331	0.69375	0.87351
"302"	"Aldosterone synthesis and secretion"	83	-1.6063	0.92536	1	1.6063	0.074636	0.32804	0.43736	0.021368	0.063698	39	-0.59201	0.12056	0.28841	44	1.1581	0.09366	0.30342
"303"	"Alcoholism"	177	-0.19967	0.40805	1	0.19967	0.59195	0.88879	-8.3411	0.99997	1	92	-4.4331	0.93596	0.98339	79	-2.1594	0.94448	1
"304"	"Alanine, aspartate and glutamate metabolism"	35	2.1895	0.0087084	0.22714	-2.1895	0.99129	1	-1.4385	0.52985	0.66604	26	-0.5721	0.18467	0.36783	9	-1.8643	0.93121	1
"305"	"African trypanosomiasis"	32	-1.373	0.89391	1	1.373	0.10609	0.38711	-0.077427	0.15965	0.2898	11	0.31356	0.1355	0.3085	21	-0.32252	0.53561	0.77119
"306"	"Adrenergic signaling in cardiomyocytes"	140	1.5442	0.023436	0.30566	-1.5442	0.97656	1	2.277	2.7364e-05	0.0012235	74	3.2022	2.2798e-08	7.0901e-06	65	0.94338	0.11215	0.33224
"307"	"Adipocytokine signaling pathway"	70	-0.22441	0.48267	1	0.22441	0.51733	0.84336	0.33166	0.032429	0.085399	35	-0.18374	0.067874	0.19545	35	0.65278	0.19826	0.45673
"308"	"Adherens junction"	70	0.058044	0.37036	1	-0.058044	0.62964	0.9263	-0.37149	0.10105	0.19892	34	0.25914	0.033598	0.13749	36	-0.76985	0.66102	0.85804
"309"	"Acute myeloid leukemia"	54	-2.0899	0.97188	1	2.0899	0.028115	0.2	2.0611	0.0020554	0.011914	24	-0.23291	0.13306	0.30726	30	2.9735	0.00098155	0.032233
"310"	"AMPK signaling pathway"	121	0.98346	0.0957	0.69661	-0.98346	0.9043	1	1.9695	0.00036631	0.0042004	64	1.7597	8.7601e-05	0.0028199	57	1.0049	0.098663	0.31633
"311"	"AGE-RAGE signaling pathway in diabetic complications"	99	-1.5459	0.88895	1	1.5459	0.11105	0.39498	1.9906	0.00055076	0.0055609	40	1.7086	0.0003133	0.0046398	59	1.1717	0.082495	0.28297
"312"	"ABC transporters"	44	-1.5948	0.92244	1	1.5948	0.077557	0.32804	-0.76433	0.28855	0.43951	19	-1.6031	0.60886	0.79229	25	0.38353	0.29806	0.58453
"313"	"2-Oxocarboxylic acid metabolism"	17	1.3604	0.076071	0.58074	-1.3604	0.92393	1	-1.8184	0.75133	0.85515	11	-0.72082	0.42866	0.60598	6	-2.0848	0.95863	1
